期刊文献+

整合素与肿瘤的转移与血管生成 被引量:2

Relationship Between Integrins and Tumor's Metastasis and Angiogenesis
下载PDF
导出
摘要 整合素是一类介导细胞与细胞外基质及细胞与细胞间黏附的细胞黏附分子受体,肿瘤细胞与胞外基质的相互作用对肿瘤的生成及转移有着重要的影响,整合素在肿瘤的生成、侵袭、转移以及肿瘤血管的生成过程中起着重要的作用。本文对整合素的结构、功能,以及它在肿瘤的血管生成过程中的作用,它与细胞外基质间的相互关系做了介绍。 The integrin family is the important receptor of cellular adhension molecules, which mediates the adhension between cell and cell or cell and cell extracellular matrix. The interaction between tumor cells and the ECM strongly influences tumor development, affecting cell proliferation and the survival, as well as the ability to migrate beyond the original location into other tissues to form metastasis. Many of these interactions are mediated by integTins. It plays a significant role in tumor devolopment, invasion and metastasis. This article reviews the construction and function of integTins, evaluates the role for integrins in tumor anglogenesis, and the relationship between integrins and the extracellular matrix.
作者 张丽 叶志义
出处 《现代生物医学进展》 CAS 2007年第2期290-292,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金(30570453) 重庆大学大学生创新基金
关键词 整合素 肿瘤 细胞外基质 血管生成 Integrin Tumor Extracellular matrix Angiogenesis
  • 相关文献

参考文献21

  • 1RUOSLAHTI E.Fibronectin and its integrin receptors in cancer[J].Adv Cancer Res,1999,76:1-20
  • 2KOKO KATAGIRI K,MASAKAZU HATTORI,NAGAHIRO MINATO,et al.Rapl is a potent activation signal for leukocyte function-associated antigenl distinct from protein kinase C and phosphatidy linositol-3-OH kinase[J].Mol.Cell.Biol,2000,20:1956-1969
  • 3JOHN Y.-J SHYY,SHU CHIEN.Role of integrins in endothelial mechanosensing of shear stress[J].Circ.Res,2002,91:769~775
  • 4BOUDREAU NJ,JONES PL.Extracellular matrix and integrin signalling:the shape of things to come[J].Bioehem J,1999,339(Pt 3):481-488
  • 5王季堃.整合素α6亚单位和肿瘤的发生、发展与转移[J].生物技术通讯,2003,14(4):330-332. 被引量:1
  • 6VOGELMANN R,KREUSER ED.Integrin alpha6betal role in metastatic behavior of human pancreatic carcinoma cells[J].Int J cancer,1999,80(5):791
  • 7PETER J.M.STROEKEN,ELLEN A.M.VAN RIJTHOVEN,MARTIN A.VAN DER VALK,et al.Target-ed disruption of the β 1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity[J].Cancer Res,1998,58:1569
  • 8MUKHOPADHYAY R,THERIAULT RL,PRICEJE,et al.Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells[J].Clin Exp Metastasis,1999,17 (4):325
  • 9孙成法,褚容涛.整合素与肿瘤血管生成[J].肿瘤学杂志,2004,10(5):357-359. 被引量:5
  • 10叶丽平 ,温有锋 ,许德顺 .整合素与肿瘤转移[J].肿瘤学杂志,2004,10(2):117-119. 被引量:4

二级参考文献74

  • 1杨晓冬,朱理玮.整合素α_vβ_3与恶性肿瘤侵袭转移关系的研究进展[J].天津医科大学学报,2004,10(S1):68-70. 被引量:3
  • 2傅遍红,吴泽志,董澄,秦建.整合素beta1亚单位对肝癌细胞与IV型胶原黏附与趋化行为的影响[J].生物医学工程学杂志,2004,21(5):741-745. 被引量:8
  • 3[1]Hood JD, Cheresh DA. Role of integrins in cell invasion and migration[J]. Nat Rev Cancer,2002, 2(2):91-100.
  • 4[2]Green LJ, Mould AP, Humphries MJ. The integrin beta subunit[J]. Int J Biochem Cell Biol, 1998, 30(2):179-184.
  • 5[3]Alford D, Pitha-Rowe P, Taylor-Papadimitriou J. Adhesion molecules in breast cancer: role of alpha 2 beta 1 integrin[J].Biochem Soc Symp, 1998,63:245-259.
  • 6[4]Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion[J]. Cancer Lett, 2003,194(1):1-11.
  • 7[5]Sanders RJ, Mainiero F, Giancotti FG. The role of integrins in tumorigenesis and metastasis [J]. Cancer Invest,1998,16(5): 329-344.
  • 8[6]Ellis LM. A targeted approach for antiangiogenic therapy of metastatic human colon cancer[J]. Am Surg,2003,69(1):3-10.
  • 9[7]Koukoulis GK, Patriarca C,Gould VE. Adhesion molecules and tumor metastasis[J]. Hum Pathol, 1998,29(9):889-892.
  • 10[8]Adachi M, Taki T, Higashiyama M, et al. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer[J]. Clin Cancer Res, 2000, 6(1):96-101.

共引文献48

同被引文献29

  • 1郭滟,任大宏,杨静,熊密.纤维连接蛋白及整合素β_1与人脑胶质瘤生物学行为的相关性研究[J].华中科技大学学报(医学版),2004,33(4):393-397. 被引量:2
  • 2袁修华,郭海泉,邱雪鹏,康传清,刘旭东,高连勋.一步法合成沙利度胺及其重要的衍生物[J].高等学校化学学报,2005,26(8):1477-1479. 被引量:5
  • 3尤启冬.药物化学[M].北京:化学工业出版社,2003,527-529.
  • 4Ruchelman AL, Man HW, Zhang W. Isosteric analogs of Lenalido- mide and Pomalidomide, Synthesis and biological activity [J]. Bioorg Med Chem Lett, 2013, 23(1): 360-365.
  • 5Ng SSW, Brown M, Figg WD. Thalidomide, an antiangiogenic agent with clinical activity in cancer [J]. Biomed. Pharmacother., 2002, 56 (4): 194-199.
  • 6Tahir L, Nabeel C, Rashid K, et al. Thalidomide and its analogues in the treatment of multiple myeloma [J]. Experimental Hematology & Ontology, 2012, 1:27.
  • 7Mohamed Z, Christian J. Biomarkers for predicting or monitoring the efficacy of a treatment for multiple myeloma: WO, 2012145309A1 [P]. 2012-10-26.
  • 8Saini N and Mahindra A , Novel immunomodulatory compounds in multiple myeloma[J]. Expert Opinion on Investigational Drugs, 2013, 22(2): 207-215.
  • 9Zhu D, Corral GL, Fleming YW, et al. Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation [J]. Cancer Immunol Immunother, 2008, 57(12): 1849-1859.
  • 10Pepin CC, Parat AU, Perino SA, et al. Preliminary biological evalua- tions of new thalidomide analogues for multiple sclerosis application [J]. Bioorg Med Chem Lett, 2009, 19(3): 878-881.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部